titanium dioxide has been researched along with Seroma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leknes, KN; Polimeni, G; Qahash, M; Susin, C; Wikesjö, UM; Yang, J | 1 |
| Hall, J; Polimeni, G; Qahash, M; Rohrer, MD; Shanaman, RH; Susin, C; Wikesjö, UM; Wozney, JM | 1 |
| Cortella, CA; Decker, JF; Hall, J; Lee, J; Polimeni, G; Rohrer, MD; Susin, C; Wikesjö, UM; Wozney, JM | 1 |
3 other study(ies) available for titanium dioxide and Seroma
| Article | Year |
|---|---|
Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2: radiographic observations.
Topics: Alveolar Process; Alveolar Ridge Augmentation; Alveolectomy; Animals; Bicuspid; Biocompatible Materials; Bone Morphogenetic Protein 2; Bone Resorption; Dental Implants; Dental Prosthesis Design; Dogs; Drug Carriers; Humans; Male; Osteogenesis; Radiography; Random Allocation; Recombinant Proteins; Seroma; Surface Properties; Surgical Flaps; Time Factors; Titanium; Tooth Extraction | 2008 |
Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2: histologic observations.
Topics: Alveolar Bone Loss; Alveolar Ridge Augmentation; Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Coated Materials, Biocompatible; Dental Implants; Dogs; Dose-Response Relationship, Drug; Humans; Implants, Experimental; Male; Osseointegration; Random Allocation; Recombinant Proteins; Seroma; Surface Properties; Titanium; Transforming Growth Factor beta | 2008 |
Evaluation of implants coated with rhBMP-2 using two different coating strategies: a critical-size supraalveolar peri-implant defect study in dogs.
Topics: Alveolar Bone Loss; Animals; Bone Density; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Remodeling; Coated Materials, Biocompatible; Dental Implants; Dental Materials; Dental Prosthesis Design; Dogs; Fluorescent Dyes; Humans; Male; Mandibular Diseases; Microscopy, Electron, Scanning; Osseointegration; Osteogenesis; Oxytetracycline; Porosity; Postoperative Complications; Recombinant Proteins; Seroma; Surface Properties; Titanium; Transforming Growth Factor beta; Wound Healing | 2010 |